Pharmacy Loans & Acquisition Finance

Yes. Pharmacy acquisition finance is available from lenders who understand the sector. They look at dispensing volumes, NHS income, the services offered, the lease, and your experience as a pharmacist or operator. Stock also has to be funded on completion. We help structure the purchase and the working capital around it before approaching lenders.

Goodwill in a pharmacy is largely tied to the NHS contract and dispensing income, together with services and retail sales. Lenders look at item volumes and their trend, local competition and the premises. A specialist valuation is usually required, and lenders may support less than the agreed price, so the structure of the deal matters.

Yes. NHS reimbursement is paid in arrears while stock is bought now, which puts pressure on working capital, particularly after an acquisition or when volumes grow. Working capital facilities can bridge that timing gap. We look at your payment cycle and supplier terms, then search the market for lenders who understand how pharmacies are paid.

Usually, yes. Dispensing automation and related technology can typically be funded through asset finance or leasing, so the cost is spread while the time saved supports the business. Lenders will look at the pharmacy's trading and the supplier. We can compare supplier finance with alternatives available across the market.

Yes. Adding a branch to an existing group is often assessed on the combined business, including the performance of the current pharmacies and the target. Lenders may also look at existing borrowing and how the group is managed. We review the whole group position and search the market for lenders suited to multi-site pharmacy owners.